The announcement leaves the impression, this is the biggest deal so far. Initially they develop cell peetrating phylomers, which could expand to 10 new drug candidates.
Looks like they may have even chosen to licence a block, maybe even without actually choosing which disease targets as yet.
In the Shareholders update "transformational period given the quantity and qUantity of current discussions" also points to much bigger deals.
The three deals mooted last year might be expanding in size and scope. Big Pharma dont rush. With NW clearly out talking up his book again even after the crticism he received, tells us he really does have a lot of negotiating happening..
Its not a trivial acheivement to sign 4 out 5 top Pharma by a tiny Bio.
Each one of those 10 drug candidates could carry upfronts and ilestones and royalties. So this deal may be up to ten times bigger than previoys deals.
And more importantly, it is further validation, PYC has some very valuable technology. These 4 companies are seeing something that is getting them excited.
PYC Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)